Attendees:
2Lyora
3B Future Health Ventures
3i Group plc
4BIO Capital
7G BioVentures
AAA Family Office
AATec Medical GmbH
AbbVie
AbbVie Ventures
abcDNA GmbH
Ability Pharmaceuticals SA
AdBio Partners
AdCab (under University of Helsinki)
Adularia AG
AFK & Partners Asset Management LLC
AION Labs
Aixial Group
Alder Therapeutics AB
AlgenScribe SAS
Algiax Pharmaceuticals GmbH
Alkapharmics SARL
Allegro N.V.
ALSA Ventures
AltamarCAM Partners
Alzheimer's Drug Discovery Foundation
AM-Pharma B.V.
Ampleia
Amporin Pharmaceuticals AG
AMR Action Fund GP GmbH
Anaveon AG
Andera Partners SA
Angelini Ventures S.p.A.
APR Applied Pharma Research s.a.
Arc Health Inc.
ARCHIMED
Arcinova
ARENSIA Exploratory Medicine
Arivin Therapeutics Ltd.
Arphamid Therapeutics SAS
ARTCLINE GmbH
Ascension
Asian Innovation and Finance Center (AIFC)
Asklepios Advisors
Astr Partners
AstraZeneca
Avance Life Sciences
AVANTECA Partners AG
Awen GmbH
Baker McKenzie
BaseLaunch
Bayer AG
BB Biotech
Bellevue Asset Management AG
BeOne Medicines I GmbH
Bergmann zur Hausen & Cie. GmbH
Berlin Institute of Health at Charité (BIH)
BERNINA BioInvest Ltd.
BIOCELL LTD.
Biocytogen Pharmaceuticals (Beijing) Co.
BioGeneration Ventures
BioInnovation Institute
BioMedPartners AG
BioMedVC AG
Biopôle SA
Bioqube Ventures
BIOSTART Consulting GmbH
biotx.ai GmbH
BioXconomy
BirchBioMed Inc.
BlackRock
Bloomberg Intelligence
Bloomberg L.P.
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Venture Fund GmbH
BOHE Angel Fund
Bootstrap Europe
Boyden Global Executive Search AG
Bpifrance
Brenus Pharma
Breslin AG
Brutkasten GmbH / VentureCapital Magazin
Business Angels Switzerland
Caedo Oncology
Cancer Research Horizons
Canton of Basel-Stadt
Capital Grand Est
CDP Venture Capital SGR S.p.A.
CDR-Life AG
Celex Oncology Innovations Limited
Cereno Scientific AB
Chromos Labs
Chugai Venture Fund
CIS BIOPHARMA AG
Claris Ventures
ClavystBio
ClearideBio Therapeutics AG
CNS Pharmaceuticals
Cohesion Bureau
Corinthian Financial Management SARL
Coulter Partners
Covington & Burling LLP
CPTx GmbH
Criteria Bio Ventures
Cube Labs SpA
Cue Biopharma
Cukierman & Co. Life Sciences
Cullgen Inc.
Curlim
Cytora
Davis Polk & Wardwell LLP
DCRM Sciences
DCVC Bio
DeBere Capital Partners
Debiopharm International SA
Delin Ventures
Desitin Arzneimittel GmbH
Diamante Società Benefit Srl
Digital Networks PLC
Dimericon Therapeutics AG
Disco Pharmaceuticals GmbH
docdok.health Ltd.
Droia Ventures
Eight Bridges
EIT Health e.V.
Elaia Partners
eleva GmbH
Eli Lilly and Company
Eliraz Ventures
Engimmune Therapeutics AG
ESC Advisors
European Investment Fund
Evernow Publishing Ltd
Evidenze
ExcellGene SA
F. Hoffmann-La Roche AG
FatiAbGen International GmbH
Finanz und Wirtschaft
Fine Treatment Limited
FINNCURE Ltd.
Flagship Pioneering
Flerie
Fontaine Capital
Forbion
Forty51 Ventures AG
FoRx Therapeutics AG
Fountain Healthcare Partners
FreeMind Group
Fund+
FundaMental Pharma GmbH
Galimedix Therapeutics
Genclis SA
Genesis Capital
Genius Search GmbH & Co. KG
Genmab A/S
GETEC PARK.SWISS AG
GIBF
Gilde Healthcare Partners B.V.
Gimv
GL Capital Group
GOLDTRACK Ventures GmbH
Grabulovski Consulting Services GmbH
GrayBella Capital
GSK
H. Lundbeck A/S
H.C. Wainwright & Co.
Hadasit Ltd.
HanchorBio Inc.
HBM Partners AG
HCRx
HealthCap
HEPHAISTOS Pharma
High-Tech Gründerfonds Management GmbH
Hikma Ventures
Hoba Therapeutics ApS
Hong Kong Exchanges and Clearing Limited (HKEX)
Hong Kong Trade Development Council
i3 Partners GmbH
ICF Consult Switzerland
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Immunethep
Indaco Venture Partners SGR S.p.A.
Industrifonden
InnoUp Farma
Innovestor Life Science Ltd.
Inotrem S.A.
Intermediate Capital Group PLC
InvestHK
IPF Partners
Ipsomel Innovations
Italian Angels for Growth (IAG)
JFG Life Sciences Stiftung der Universität Basel
JLP Health GmbH
JMI Capital Group
Johnson & Johnson Innovation LLC
KBI Biopharma
KdT Ventures
Kerna Ventures
KHAN Technology Transfer Fund
King Bioventures
KKR
Ksilink
Kurma Partners
Landmark BioVentures AG
Laverock Therapeutics Ltd.
Leads To Development
LifeCare Partners GmbH
LIfT BioSciences Ltd.
Limani Partners
LMU Munich
Loma Therapeutics
M&G Advisors GmbH
M2care
MC Services AG
Medicines Discovery Ventures
MEDiSTRAVA
Melio Bio
Memo Therapeutics AG
Merck KGaA
metaLead Therapeutics AG
Mighto Therapeutics
MitoRx Therapeutics
Mitsubishi Tanabe Pharma America
ModernVivo
Modi VC
Montis Biosciences BV
MSD
Nanolattix
NanoTherix
ND Capital
Neurochlore
New Science Fund
NG Bio Ltd
NLC Health Ventures
NodThera
Nomal Therapeutics
Noscendo GmbH
NoToVir Srl
Nouscom AG
Novac BiotechBD
Novartis AG
Novartis Pharma AG
Novartis Venture Fund
Novo Holdings A/S
NRW.Bank
NxR Biotechnologies GmbH
Olgram SAS
OmnilinX Therapeutics AG
Ona Therapeutics
Oncode Accelerator
Oncomatryx Biopharma S.L.
Oncovita
Onena Medicines AG
OphthaNova Therapeutics AG
Oppenheimer & Co. Inc.
Organos
Origenis GmbH
Orikine Bio
OrthoTreat
Oryzon Genomics
Otsuka America Pharmaceutical
Oxford Science Enterprises
OxSonics
Pace Ventures
palleos healthcare GmbH
Pappas Capital LLC
Pathios Therapeutics Limited
Perogative LLC
Perseo Pharma AG
Pharmaron UK Ltd
Pharmell Life Sciences SA
Pharming Group NV
Pilatus Biosciences SA
Platypus
Playground Global
Pleco Therapeutics BV
Pluvia Biotech
PMIC Advisors Group Ltd.
Primo Capital SGR S.p.A.
Procavea Biotech AG
Pureos Bioventures
Qualified Capital
QuantHealth
Recordati Pharma GmbH
RedHill Biopharma Ltd.
remynd NV
Roche Diagnostics
Ropes & Gray LLP
Rosetta Capital Ltd.
RV Invest
Ryvu Therapeutics
Salvina Therapeutics AG
Sanavia Oncology
Sanofi
SAPPIENS SAS
SCI Ventures LLC
Scius Communications
Secarna Pharmaceuticals GmbH & Co. KG
Selvita S.A.
Sen-Jam Pharmaceutical
Senya Therapeutics
Seqens
Serca Pharmaceuticals AS
Serenatis Bio
Seroba Life Sciences
Sherpa Healthcare Partners
SILREAL GmbH
SixPeaks Bio AG
Sobi
Sofinnova Investments
SOTIO Biotech a.s.
Sound Bioventures Management AB
SPARK Finland
Staatz BD & Strategy
Staatz Business Development & Strategy
STALICLA SA
Stifel
Strategic Transactions Advisory AG
Stromal Therapeutics AG
Sunstone Life Science Ventures
Superlab Suisse AG
Suterscience GmbH
Swiss Biotech Association
SWISS IMMUNE | Amedioo EDC
Swiss Investment Management SA
SynuCa Therapeutics
T-knife Therapeutics
TargImmune Therapeutics AG
Teitur Trophics ApS
Telomere Therapeutics
Tessara Therapeutics Pty Ltd.
The Fulford Group Ltd.
TheraVenture GmbH
TiVentures SA
TOLREMO Therapeutics AG
TransCure bioServices SAS
Tridek-One Therapeutics
Turbine Ltd.
UBS AG
UCEA Family Office
Umlaut.bio GmbH
University of Basel Innovation Office
University of Zurich
UPyTher B.V.
USI Startup Centre
V-Bio Ventures BV
Valor Management
Valpharma Group SpA
Vandria SA
Venture Valuation AG
Versant Ventures
Verve Ventures
Vesalius Biocapital IV Partners SàRL
Vesna Deeptech VC
VI Partners AG
VIB
Viopas Venture Consulting GmbH
Vogel BioC
VUS Genetics
Wellington Partners
Worldwide Clinical Trials
XGen Venture SGR S.p.A.
Xlife Sciences AG
YAYA Capital
Ysios Capital
Zinc VC
Last updated: November 17, 2025